Name:
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide)
Type:
Synthetic opioid
AKA:
Acryloylfentanyl
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) image
Synthetic substance, no natural derivative
IUPAC Logo
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) image
Acryl fentanyl, a synthetic opioid, was first identified in the early 2010s as part of research into fentanyl analogs. It was developed to have similar effects to fentanyl but with slight chemical modifications. Acryl fentanyl's introduction to the illicit drug market was part of a broader trend towards the creation of new synthetic opioids. Its potent effects and high potential for overdose led to regulatory actions aimed at controlling its distribution and addressing public health concerns.
Synthetic Substances Image
Acryl fentanyl is a potent synthetic opioid with high analgesic effects. It acts as a downer, causing significant sedation and respiratory depression. Short-term use provides pain relief, but long-term use can result in addiction and tolerance. Overdose risks include severe respiratory depression and potential death. Safe use involves careful dosing and medical supervision. Recent studies investigate its potency and potential risks compared to other opioids.
N/A
Acryl fentanyl is a potent opioid with strong analgesic and euphoric effects. Long-term use can lead to severe addiction, cognitive impairments, and mood disorders. Research highlights its impact on opioid receptors and associated psychological risks.
N/A
Acryl fentanyl is a synthetic opioid with potent analgesic effects, classifying it as a downer. Short-term use provides pain relief, while long-term use can lead to dependence and tolerance. Overdose risks are high, causing respiratory depression and potentially fatal outcomes. Safe dosages are strictly prescribed, often in microgram quantities. Recent research underscores its potency and associated risks of misuse. Physical effects include drowsiness, constricted pupils, and respiratory depression.
N/A